AstraZeneca

+$0.27 (+0.47%) Today
+$0.09 (+0.15%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory.

CEO
Pascal Soriot
Employees
76,100
Headquarters
Cambridge, Cambridgeshire
Founded
1992

AZN Key Statistics

Market Cap
180.41B
Price-Earnings Ratio
38.16
Dividend Yield
2.35
Average Volume
28.67M
High Today
$58.72
Low Today
$58.02
Open Price
$58.38
Volume
14.13M
52 Week High
$60.93
52 Week Low
$46.48

AZN News

ReutersJul 24

AstraZeneca scours supply chain for more vaccine doses for Thailand, SE Asia

People receive the first dose of AstraZeneca COVID-19 vaccine against the coronavirus disease (COVID-19) at the Central Vaccination Center, inside the Bang Sue
BloombergJul 24

Astra Mulls Vaccine Imports to Southeast Asia as Thai Supply Hit

(Bloomberg) -- AstraZeneca Plc is planning to import Covid-19 vaccines to Southeast Asia as its only manufacturing facility in the region struggles to ramp up
BenzingaJul 23

Analyzing AstraZeneca's Unusual Options Activity

On Friday, shares of AstraZeneca (NASDAQ:AZN) saw unusual options activity. After the option alert, the stock price moved up to $58.23. Sentiment: BULLISH Opt

AZN Earnings

$0.00
$0.33
$0.66
$0.99
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
$0.43 per share
Actual
Available Jul 29, Pre-Market

More AZN News

MarketWatchJul 23

AstraZeneca's Bydureon BCise Gets U.S. Approval For Type 2 Diabetes in Pediatric Patients

By Michael Dabaie AstraZeneca said its Bydureon BCise, or exenatide extended-release, was approved in the U.S. for the treatment of type 2 diabetes in pediatri
ReutersJul 23

AstraZeneca's once-weekly diabetes drug gets U.S. nod for children

A test tube is seen in front of displayed Alexion Pharma and AstraZeneca logos in this illustration taken on July 14, 2021. REUTERS/Dado Ruvic/Illustration Jul
BenzingaJul 23

Real-World Data In Canada Shows AstraZeneca's COVID-19 Jab Is Over 80% Effective Against Variants

Results from the Canadian Immunization Research Network (CIRN) showed that one dose of AstraZeneca Plc's (NASDAQ: AZN) COVID-19 vaccine was 82% effective agains
MarketWatchJul 23

AstraZeneca's Covid-19 Vaccine Effective Against Variants After One Dose, Canadian Study Shows

By Cecilia Butini AstraZeneca PLC said Friday that real-world data coming from Canada suggest that its Covid-19 vaccine is effective against hospitalization or
Simply Wall StJul 23

What You Need To Know About AstraZeneca PLC's Investor Composition

A look at the shareholders of AstraZeneca PLC (LON:AZN) can tell us which group is most powerful. Institutions will often hold stock in bigger companies, and we
BenzingaJul 22

Global Blood Submits US Application For Expanded Use Of SCD Drug, Oxbryta, In Patients Aged 4-11 Years

Reuters Two doses of Pfizer or AstraZeneca's COVID-19 vaccine are nearly as effective against the highly transmissible Delta coronavirus variant as they are ag
ReutersJul 22

Factbox: EU's COVID-19 vaccine donations so far

BRUSSELS (Reuters) - EU member states have pledged to share about 160 million COVID-19 vaccines, but only a small portion has been shipped so far, according to
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure